{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/pk-reporting-tool-infosheet#webpage",
"url": "https://www.fortrea.com/insights/pk-reporting-tool-infosheet",
"name": "PK Reporting Tool Infosheet",
"description": "Explore this Fortrea info sheet on PK reporting and discover how the PK Reporting Tool, powered by Fortrea Intelligent Technology (FIT), helps sponsors access preliminary pharmacokinetic results within 24 hours of receiving source data to support faster decision-making in early phase clinical trials. The info sheet highlights capabilities for pharmacokinetic reporting, interactive review of PK profiles, participant-level analysis, adverse event review, PK parameter evaluation, and customizable reporting outputs that help study teams review and interpret PK data more efficiently. Learn how rapid access to pharmacokinetic results, interactive dashboards, participant-level drill-down capabilities, and support for regulatory submission deliverables can help accelerate study timelines, improve reporting workflows, strengthen clinical pharmacology decision-making, and support progression into later phase clinical development programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "PK Reporting Tool Infosheet",
"item": "https://www.fortrea.com/insights/pk-reporting-tool-infosheet"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/pk-reporting-tool-infosheet#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/pk-reporting-tool-infosheet#webpage"
},
"headline": "PK Reporting for Pharmacokinetic Results, PK Profile Review, and Regulatory Submission Deliverables | Fortrea Info Sheet",
"description": "Explore this Fortrea info sheet on PK reporting and discover how the PK Reporting Tool, powered by Fortrea Intelligent Technology (FIT), helps sponsors access preliminary pharmacokinetic results within 24 hours of receiving source data to support faster decision-making in early phase clinical trials. The info sheet highlights capabilities for pharmacokinetic reporting, interactive review of PK profiles, participant-level analysis, adverse event review, PK parameter evaluation, and customizable reporting outputs that help study teams review and interpret PK data more efficiently. Learn how rapid access to pharmacokinetic results, interactive dashboards, participant-level drill-down capabilities, and support for regulatory submission deliverables can help accelerate study timelines, improve reporting workflows, strengthen clinical pharmacology decision-making, and support progression into later phase clinical development programs.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-06",
"dateModified": "2026-04-06",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/pk-reporting-tool.pdf",
"encodingFormat": "application/pdf"
}
}
]
}